アニマルヘルス市場レポート：動物タイプ、製品タイプ、地域別、2024年～2032年

世界のアニマルヘルス市場規模は、2023年に378億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて2.9%の成長率（CAGR）を示し、2032年までに495億米ドルに達すると予測しています。ペットの飼い主の増加と質の高い獣医療に対する彼らの要望、人獣共通感染症に対する意識の高まり、数々の技術的進歩が市場を推進する主な要因の一部です。

アニマルヘルスとは、家畜および野生動物の幸福と適切な機能の状態を指します。動物の身体的、精神的、行動的側面を包含し、全体的な健康と生活の質を重視します。アニマルヘルスを確保するには、予防医療、適時のワクチン接種、適切な栄養摂取、定期的な獣医療など、さまざまな対策を講じる必要があります。アニマルヘルスを適切に管理することは、個々の動物の福祉のため、そして動物と人間の両方の集団に影響を与える可能性のある疾病の蔓延を予防し、制御するために不可欠です。その結果、アニマルヘルスは、持続可能な農業、野生動物の保護、そして社会における人間と動物の絆を支える重要な役割を果たします。

動物性タンパク質に対する需要の高まりとペット飼育率の増加は、予測期間中の市場の成長を刺激すると思われます。さらに、人獣共通感染症に対する意識の高まりとワンヘルスアプローチにより、動物の予防医療と疾病管理の重要性が強調されています。これに伴い、新しく改良された動物用健康ソリューションの研究開発（R&D）への広範な投資が、市場成長にプラスの影響を与えています。これとは別に、アニマルヘルス介入の有効性を高める革新的な診断、医薬品、治療方法など、獣医学における数多くの技術的進歩が、高度な獣医学製品の需要を増大させています。さらに、動物福祉とバイオセキュリティの促進を目的とした政府の有利な規制とイニシアチブが、市場の成長を後押ししています。これに加えて、食品の安全性と品質への注目の高まりが、より健康で安全な食品サプライチェーンを確保するために、家畜生産における動物用衛生製品の採用を加速させています。さらに、新興国における可処分所得の増加により、ペットケアに対する消費者の支出が増加していることも、市場の成長に寄与しています。

アニマルヘルス市場の動向と促進要因：

予防ヘルスケアへの注目の高まり

アニマルヘルス業界では、コンパニオンアニマルや家畜の予防ヘルスケアへのシフトが著しいです。ペットの飼い主や家畜生産者は、動物全体の幸福を向上させ病気のリスクを減らすために、健康問題の早期発見と事前管理の重要性を認識しています。獣医師による定期的な健康診断、ワクチン接種、それぞれに合った健康管理プランが一般的になりつつあります。この動向は、家畜の生活の質を向上させ、畜産における疾病発生による経済的影響を最小限に抑えたいという願望に後押しされています。その結果、ワクチン、寄生虫駆除剤、栄養補助食品など、予防的なアニマルヘルスに対する需要が高まっています。

バイオテクノロジーと医薬品の進歩

アニマルヘルスの分野では、バイオテクノロジーや医薬品の進歩が目覚ましく、動物の病気の診断や治療方法が大きく変わってきています。最先端の研究と革新的技術により、特定の動物種や病態に合わせた特殊療法、ワクチン、精密医療が開発されています。遺伝子編集や細胞ベースの治療といったバイオテクノロジーの飛躍的進歩は、課題となっている疾患に対する有望な解決策を提供しています。さらに製薬会社は、動物により効果的で安全な医薬品を開発するための研究開発（R&D）に投資しています。こうした進歩は治療成績を向上させ、動物ヘルスケア全体の効率化に貢献しています。獣医の専門家たちは、より的を絞った個別化された治療計画を提供できるようになり、その結果、治療を受けている動物たちの治療成績が向上し、生活の質が向上しています。

高まるペットの人間化と専門的ペットケア

人間とペットとの関係の進化は、ペットの人間化として知られる現象につながっています。ペットはますます重要な家族の一員とみなされるようになり、その結果、ペットケア市場における消費者行動に大きな変化が生じています。ペットの飼い主は、愛するペットが健康で充実した生活を送れるよう、高級で専門的なペットケア製品やサービスに積極的に出費するようになった。この動向は、高品質のペット用栄養製品、個別化された治療法、高度な獣医療に対する需要を喚起しています。オーガニックのペットフード、カスタマイズされたサプリメント、ペット専用の医療処置など、幅広い専門製品の入手可能性が、アニマルヘルス市場の成長を後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 アニマルヘルスの世界市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：動物タイプ別
• 市場内訳：製品タイプ別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：動物タイプ別

• 商業
  • 市場動向
  • 市場予測
• コンパニオン
  • 市場動向
  • 市場予測

第7章 市場内訳：製品タイプ別

• 医薬品
  • 市場動向
  • 市場予測
• バイオ
  • 市場動向
  • 市場予測
• 薬用飼料添加物
  • 市場動向
  • 市場予測
• 診断薬
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• アジア太平洋
  • 市場動向
  • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測

第9章 世界のアニマルヘルス産業SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 世界のアニマルヘルス産業：バリューチェーン分析

第11章 世界のアニマルヘルス産業：ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 世界のアニマルヘルス産業：価格分析

• 主な価格指標
• 価格構造
• マージン分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Bayer
  • Elanco
  • Merck
  • Merial
  • Zoetis Inc.
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Heska
  • Neogen
  • Novartis
  • Thermo Fisher Scientific
  • Vetoquinol
  • Virbac

List of Figures

• Figure 1: Global: Animal Health Market: Major Drivers and Challenges
• Figure 2: Global: Animal Health Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Animal Health Market: Breakup by Animal Type (in %), 2023
• Figure 4: Global: Animal Health Market: Breakup by Product Type (in %), 2023
• Figure 5: Global: Animal Health Market: Breakup by Region (in %), 2023
• Figure 6: Global: Animal Health Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 7: Global: Animal Health Industry: SWOT Analysis
• Figure 8: Global: Animal Health Industry: Value Chain Analysis
• Figure 9: Global: Animal Health Industry: Porter's Five Forces Analysis
• Figure 10: Global: Animal Health (Commercial) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Animal Health (Commercial) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Animal Health (Companion) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Animal Health (Companion) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Animal Health (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Animal Health (Biologicals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Animal Health (Biologicals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Animal Health (Medicinal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Animal Health (Medicinal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Animal Health (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Animal Health (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: North America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: North America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Europe: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Europe: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Asia Pacific: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Asia Pacific: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Middle East and Africa: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Middle East and Africa: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Latin America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Latin America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

• Table 1: Global: Animal Health Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Animal Health Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
• Table 3: Global: Animal Health Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
• Table 4: Global: Animal Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 5: Global: Animal Health Market: Competitive Structure
• Table 6: Global: Animal Health Market: Key Players

Abstract

The global animal health market size reached US$ 37.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The increasing number of pet owners and their desire for high-quality veterinary care, rising awareness of zoonotic diseases, and numerous technological advancements are some of the major factors propelling the market.

Animal health refers to the state of well-being and proper functioning of animals, both domestic and wild. It encompasses the physical, mental, and behavioral aspects of animals, emphasizing their overall health and quality of life. Ensuring animal health involves taking various measures, such as preventive healthcare, timely vaccinations, appropriate nutrition, and regular veterinary care. Proper management of animal health is essential for the welfare of individual animals and for preventing and controlling the spread of diseases that can impact both animal and human populations. As a result, animal health plays a crucial role in supporting sustainable agriculture, wildlife conservation, and the human-animal bond in society.

The rising demand for animal protein and the growing pet ownership rate will stimulate the growth of the market during the forecast period. Moreover, the heightening awareness of zoonotic diseases and the One Health approach have emphasized the importance of preventive care and disease management in animals. In line with this, extensive investments in research and development (R&D) of new and improved animal health solutions are positively influencing the market growth. Apart from this, numerous technological advancements in veterinary medicine, such as innovative diagnostics, pharmaceuticals, and treatment modalities that enhance the effectiveness of animal health interventions, has augmented the demand for advanced veterinary products. Additionally, favorable government regulations and initiatives aimed at promoting animal welfare and biosecurity are propelling the market growth. Besides this, the increasing focus on food safety and quality has accelerated the adoption of animal health products in livestock production to ensure healthier and safer food supply chains. Furthermore, the inflating consumer spending on pet care due to rising disposable incomes in emerging economies is contributing to the market growth.

Animal Health Market Trends/Drivers:

Increasing focus on preventive healthcare

The animal health industry is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet owners and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. Regular veterinary check-ups, vaccinations, and tailored health management plans are becoming commonplace. This trend is fueled by a desire to enhance the quality of life for animals and minimize the economic impact of disease outbreaks in livestock production. As a result, there is a growing demand for preventive animal health products, including vaccines, parasiticides, and nutritional supplements.

Advancements in biotechnology and pharmaceuticals

The animal health sector is witnessing remarkable advancements in biotechnology and pharmaceuticals, transforming the way diseases are diagnosed and treated in animals. Cutting-edge research and innovative technologies have led to the development of specialized therapies, vaccines, and precision medicine tailored to specific animal species and conditions. Biotechnological breakthroughs, such as gene editing and cell-based therapies, offer promising solutions for challenging diseases. Additionally, pharmaceutical companies are investing in research and development (R&D) to create more effective and safer medications for animals. These advancements improve treatment outcomes and contribute to the overall efficiency of animal healthcare. Veterinary professionals can now offer more targeted and personalized treatment plans, leading to better outcomes and enhanced quality of life for animals under their care.

Growing pet humanization and specialty pet care

The evolving relationship between humans and their pets has led to a phenomenon known as pet humanization. Pets are increasingly regarded as integral family members, resulting in a significant shift in consumer behavior in the pet care market. Pet owners are now willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend has catalyzed the demand for high-quality pet nutrition products, personalized treatments, and advanced veterinary care. The availability of a wide range of specialty products, such as organic pet food, customized supplements, and pet-specific medical treatments is propelling the growth of the market for animal health.

Animal Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global animal health market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on animal type and product type.

Breakup by Animal Type:

Commercial

Companion

Commercial holds the largest share in the market

A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes commercial and companion. According to the report, commercial accounted for the largest market share.

The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, has augmented the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus favoring the market growth.

Breakup by Product Type:

Pharmaceuticals

Biologicals

Medicinal Feed Additives

Diagnostics

Pharmaceuticals represent the most popular product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes pharmaceuticals, biologicals, medicinal feed additives, and diagnostics. According to the report, pharmaceuticals represented the largest segment.

Pharmaceuticals refer to essential medications and therapies used to address a wide range of health conditions in animals. These pharmaceutical products cater to both companion animals and livestock, helping prevent and treat diseases, manage chronic conditions, and enhance overall animal well-being. Veterinary pharmaceutical companies are investing heavily in research and development (R&D) to create innovative and effective drugs tailored to specific animal species and health needs, thereby contributing to the segment growth. Moreover, continuous advancements in pharmaceutical technologies, such as controlled-release formulations and personalized medicine, further optimizes treatment outcomes. Additionally, pharmaceutical companies are collaborating with veterinarians, animal owners, and regulatory authorities to ensure product safety, efficacy, and compliance with stringent quality standards. Furthermore, the increasing demand for animal healthcare and the growing importance of preventive medicines are propelling the market growth.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region has a large population of pet owners who prioritize the health and well-being of their companion animals, which has augmented demand for veterinary products and services. Moreover, the expanding livestock industry in North America fuels the need for animal health solutions to ensure the health and productivity of the commercial animal sector. Additionally, the presence of leading pharmaceutical companies and research institutions in the region that fosters continuous innovation in animal health products, including vaccines, pharmaceuticals, and diagnostics has catalyzed the market growth. Another major contributing aspect is the introduction of supportive government regulations and initiatives promoting animal welfare and biosecurity, encouraging investments in the animal health industry, thereby propelling the market growth.

Competitive Landscape:

The market is experiencing steady growth as key players are introducing several cutting-edge innovations to address evolving challenges and enhance animal care. They are developing advanced vaccines and therapeutics targeting specific diseases prevalent in both companion animals and livestock. Additionally, novel diagnostic tools employing advanced technologies, such as DNA testing and point-of-care devices, have been introduced by manufacturers to enable faster and more accurate disease detection. Key players are also investing in telemedicine and digital health solutions, facilitating remote consultations and personalized treatment plans for pet owners. Furthermore, the integration of data analytics and artificial intelligence (AI) technologies has improved decision-making in animal health management, optimizing treatment protocols and predictive modeling. These latest innovations by leading players in the market reflect their commitment to delivering state-of-the-art solutions and driving the animal health industry toward a more efficient and compassionate approach to animal care. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain during the forecast period (2024-2032).

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Bayer

Elanco

Merck

Merial

Zoetis Inc.

Biogenesis Bago

Boehringer Ingelheim

Ceva Sante Animale

Heska

Neogen

Novartis

Thermo Fisher Scientific

Vetoquinol

Virbac

Recent Developments:

In January 2022, Zoetis Inc., a leading animal health company, announced the U.S. Food and Drug Administration (FDA) approval of a new label indication for their product, SimparicaTrio. This groundbreaking approval grants SimparicaTrio, a chewable tablet containing sarolaner, moxidectin, and pyrantel, an extended purpose for the prevention of Borrelia burgdorferi infections in dogs. The approval is a testament to the product's potent tick-killing properties, which not only protect dogs but also contribute to the prevention of tick-borne diseases.

In January 2021, Boehringer Ingelheim, a prominent player in the animal health industry, unveiled a strategic collaboration with PetMedix, a renowned biotechnology company specializing in companion animal therapeutics. This partnership aims to harness the innovative potential of PetMedix's proprietary Ky9 platform, which is designed to develop cutting-edge antibody therapeutics for companion animals. Boehringer Ingelheim's involvement in this joint venture will focus on leveraging its extensive expertise in market access, regulatory approvals, and commercialization to bring these groundbreaking therapies to the global market.

In September 2020, Ceva Sante Animale, a leading animal health company, made a groundbreaking announcement regarding a substantial expansion in its production capacity for bacterial autogenous vaccines at its manufacturing facility in France. This impressive development represents a three-fold increase in production capability, achieved through an ambitious and forward-thinking project backed by an investment of USD 8 million. The primary focus of this innovative venture is to bolster preventative animal health measures, particularly by enhancing the availability and accessibility of bacterial autogenous vaccines.

Key Questions Answered in This Report

• 1. What was the size of the global animal health market in 2023?
• 2. What is the expected growth rate of the global animal health market during 2024-2032?
• 3. What are the key factors driving the global animal health market?
• 4. What has been the impact of COVID-19 on the global animal health market?
• 5. What is the breakup of the global animal health market based on the animal type?
• 6. What is the breakup of the global animal health market based on the product type?
• 7. What are the key regions in the global animal health market?
• 8. Who are the key players/companies in the global animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Animal Health Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Animal Type
• 5.5 Market Breakup by Product Type
• 5.6 Market Breakup by Region
• 5.7 Market Forecast

6 Market Breakup by Animal Type

• 6.1 Commercial
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Companion
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Pharmaceuticals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Biologicals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Medicinal Feed Additives
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Diagnostics
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Europe
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Asia Pacific
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Middle East and Africa
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Latin America
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Global Animal Health Industry: SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Global Animal Health Industry: Value Chain Analysis

11 Global Animal Health Industry: Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Global Animal Health Industry: Price Analysis

• 12.1 Key Price Indicators
• 12.2 Price Structure
• 12.3 Margin Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Bayer
  • 13.3.2 Elanco
  • 13.3.3 Merck
  • 13.3.4 Merial
  • 13.3.5 Zoetis Inc.
  • 13.3.6 Biogenesis Bago
  • 13.3.7 Boehringer Ingelheim
  • 13.3.8 Ceva Sante Animale
  • 13.3.9 Heska
  • 13.3.10 Neogen
  • 13.3.11 Novartis
  • 13.3.12 Thermo Fisher Scientific
  • 13.3.13 Vetoquinol
  • 13.3.14 Virbac